Nephron Pharmaceuticals Corp.
Nephron Pharmaceuticals Corp. holds FDA 510(k) medical device clearances, cleared in 2012, with 5 FDA device recalls on record.
Top product codes for Nephron Pharmaceuticals Corp.
FDA recalls by Nephron Pharmaceuticals Corp.
- Z-2054-2016 — Sodium Chloride Inhalation Solution, USP 7%, 60 x 4 mL Sterile Unit-Dose Vials, Rx Only, NDC 0487-9007-60. A vial contains sterile, preservation-free, clear, colorless, aqueous solution as labeled for induction of sputum production where specimen collection is indicated. For respiratory therapy, Solium Chloride Inhalation Solution USP, 3% is used in conjunction with a nebulizer
- Z-2053-2016 — Sodium Chloride Inhalation Solution, USP 3%, 60 x 4 mL Sterile Unit-Dose Vials per carton, Rx Only, NDC 0487-9003-60. A vial contains sterile, preservation-free, clear, colorless, aqueous solution as labeled for induction of sputum production where specimen collection is indicated. For respiratory therapy, Solium Chloride Inhalation Solution USP, 3% is used in conjunction with a nebulizer
- Z-1372-2013 — AsthmaNefrin Starter Kit contains ten (10) AsthmaNefrin vials and one (1) EZ Breathe Atomizer. For the delivery of liquid medications for respiratory usage.
- Z-1373-2013 — EZ Breathe Medication Cup. For the delivery of liquid medications for respiratory usage.
- Z-1371-2013 — EZ Breathe Atomizer Model # EZ-100. For the delivery of liquid medications for respiratory usage.
Recalls are matched by FDA's recalling-firm name — openFDA's enforcement dataset doesn't reference 510(k) numbers, so a recall here may cover devices beyond this company's 510(k) clearances.
Recent clearances by Nephron Pharmaceuticals Corp.
Data sourced from openFDA. This site is unofficial and independent of the FDA.